Eleonora Patsenker

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats.

The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats.

Journal: The Journal of nutritional biochemistry

Published: June 02, 2021

New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4.

New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4.

Journal: Inflammatory bowel diseases

Published: November 11, 2020

Loss of hepatic Mboat7 leads to liver fibrosis.

Loss of hepatic Mboat7 leads to liver fibrosis.

Journal: Gut

Published: February 07, 2020

Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice.

Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice.

Journal: Hepatology (Baltimore, Md.)

Published: April 07, 2017

4-O'-methylhonokiol protects from alcohol/carbon tetrachloride-induced liver injury in mice.

4-O'-methylhonokiol protects from alcohol/carbon tetrachloride-induced liver injury in mice.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: February 14, 2017

Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.

Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.

Journal: World journal of gastroenterology

Published: December 27, 2016

Cannabinoids in liver diseases.

Cannabinoids in liver diseases.

Journal: Clinical liver disease

Published: November 07, 2015

Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro.

Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro.

Journal: Oncotarget

Published: July 09, 2015

Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.

Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.

Journal: International journal of molecular sciences

Published: January 20, 2015

Elevated liver regeneration in response to pharmacological reduction of elevated portal venous pressure by terlipressin after partial hepatectomy.

Elevated liver regeneration in response to pharmacological reduction of elevated portal venous pressure by terlipressin after partial hepatectomy.

Journal: Transplantation

Published: March 14, 2014

K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.

K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 25, 2014

Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites.

Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 24, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026